We are live on ! Find out more
AA

AQR Arbitrage Portfolio holdings

AUM $6.09B
1-Year Est. Return 27.01%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
+27.01%
3 Year Est. Return
+77.25%
5 Year Est. Return
+160.09%
10 Year Est. Return
+1,244.43%
AUM
$2.78B
AUM Growth
-$65.9M
Cap. Flow
-$1.1B
Cap. Flow %
-39.55%
Top 10 Hldgs %
16.2%
Holding
1,575
New
503
Increased
22
Reduced
219
Closed
602

Top Buys

Rank Stock Value
1
CMD
Cantel Medical Corporation
CMD
+$32.9M
2
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
+$26.7M
3
COHR
Coherent Inc
COHR
+$24.6M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$23.3M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$23.3M

Top Sells

Rank Stock Value
1
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$36.2M
2
BMCH
BMC Stock Holdings, Inc
BMCH
+$35.8M
3
NGHC
National General Holdings Corp
NGHC
+$29.7M
4
CHNGU
Change Healthcare Inc. Tangible Equity Units
CHNGU
+$26.3M
5
EV
Eaton Vance Corp.
EV
+$25.2M

Sector Composition

Rank Sector Weight
1 Financials 10.51%
2 Healthcare 6.47%
3 Industrials 4.82%
4 Consumer Discretionary 4.5%
5 Technology 3.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COOLW
726
DELISTED
Corner Growth Acquisition Corp. Warrant
COOLW
$132K ﹤0.01%
+133,333
New +$169K
DSKEW
727
DELISTED
Daseke, Inc. Warrant
DSKEW
$128K ﹤0.01%
378,003
– –
CMIIU
728
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
$128K ﹤0.01%
+10,000
New +$126K
NVTSW
729
DELISTED
Navitas Semiconductor Corporation Warrants
NVTSW
$127K ﹤0.01%
+88,750
New +$212K
GNPK.WS
730
DELISTED
Genesis Park Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A o
GNPK.WS
$126K ﹤0.01%
+57,714
New +$105K
BGRYW
731
DELISTED
Berkshire Grey, Inc. Warrant
BGRYW
$125K ﹤0.01%
+63,333
New +$140K
SNPR.WS
732
DELISTED
Tortoise Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary shar
SNPR.WS
$123K ﹤0.01%
37,499
– –
HPX.WS
733
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
$121K ﹤0.01%
150,000
– –
FTCVW
734
DELISTED
FinTech Acquisition Corp. V Warrant
FTCVW
$120K ﹤0.01%
+49,999
New +$118K
CRHC.WS
735
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$120K ﹤0.01%
99,999
– –
MAPSW
736
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$118K ﹤0.01%
16,746
-383,254
-96% -$3.14M
BTWNW
737
DELISTED
Bridgetown Holdings Limited Warrants
BTWNW
$117K ﹤0.01%
+40,000
New +$161K
RVPHW
738
DELISTED
Reviva Pharmaceuticals Warrants
RVPHW
$115K ﹤0.01%
250,000
– –
DMYI.WS
739
DELISTED
dMY Technology Group, Inc. III Redeemable warrants, each whole warrant exercisable for one share of
DMYI.WS
$114K ﹤0.01%
+49,500
New +$145K
CYXTW
740
DELISTED
Cyxtera Technologies, Inc. Warrant
CYXTW
$113K ﹤0.01%
75,000
– –
YAC.WS
741
DELISTED
Yucaipa Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A
YAC.WS
$111K ﹤0.01%
79,166
– –
FAII.WS
742
DELISTED
Fortress Value Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class
FAII.WS
$111K ﹤0.01%
70,000
– –
PIAI.WS
743
DELISTED
Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PIAI.WS
$109K ﹤0.01%
133,333
– –
THCAW
744
DELISTED
Tuscan Holdings Corp. II Warrant
THCAW
$108K ﹤0.01%
135,456
-339,544
-71% -$612K
ENPC.WS
745
DELISTED
Executive Network Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
ENPC.WS
$105K ﹤0.01%
125,000
+75,000
+150% +$200K
AVAN.WS
746
DELISTED
Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AVAN.WS
$105K ﹤0.01%
100,000
– –
KWAC.WS
747
DELISTED
Kingswood Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
KWAC.WS
$103K ﹤0.01%
+193,622
New +$149K
GNT
748
GAMCO Natural Resources, Gold & Income Trust
GNT
$138M
$102K ﹤0.01%
20,385
-4,279
-17% -$21.6K
HZON.WS
749
DELISTED
Horizon Acquisition Corporation II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HZON.WS
$102K ﹤0.01%
49,999
– –
IPOF.WS
750
DELISTED
Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOF.WS
$99K ﹤0.01%
37,500
– –
28 29
30
31 32

Similar funds

JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return

AQR Arbitrage's Q1 2021 Portfolio in Review

As of Q1 2021, AQR Arbitrage held 1,575 positions worth $2.78B, down 2.3% from $2.85B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

AQR Arbitrage withdrew a net $1.1B in Q1 2021, closing 602 positions and reducing 219 holdings. Its most notable exit was Eidos Therapeutics, Inc. Common Stock, an estimated $36.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 9% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AQR Arbitrage opened a new position in Cantel Medical Corporation worth $33.4M.

  • AQR Arbitrage's largest Q1 2021 buy was Cantel Medical Corporation: 420,838 shares worth $33.4M.
  • AQR Arbitrage added most to PRA Health Sciences, Inc. in Q1 2021, an estimated $23.3M increase.
  • AQR Arbitrage's biggest Q1 2021 reduction was International Flavors & Fragrances Inc. 6.00% Tangible Equity Units, cutting an estimated $12.5M.
  • AQR Arbitrage fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $36.2M.
  • AQR Arbitrage's ten largest holdings make up 16% of its $2.78B portfolio in Q1 2021.
  • AQR Arbitrage opened 503 new positions and closed 602 in Q1 2021.
  • AQR Arbitrage's portfolio value fell 2.3% quarter-over-quarter to $2.78B.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.